Basser Center for BRCA Celebrates Breast Cancer Awareness Month TODAY News Susan Domchek, MD, executive director of the Basser Center, took part in a live interview on the TODAY Show with breast cancer survivor and Basser Advisory Board member Jill Martin. Latest News Basser Center for BRCA Awards 2024 Basser Global Prize to Patrick Sung, DPhil, of The University of Texas Health Science Center at San Antonio Penn Medicine News News | October 2024 Patrick Sung, DPhil, of The University of Texas Health Science Center at San Antonio is awarded the 2024 Basser Global Prize for his cutting-edge work in the field of DNA damage repair. Can We Prevent Cancer With a Shot? The Wall Street Journal News | October 2024 Healthy volunteers who carry BRCA gene mutations, like Philadelphia resident Sara Walker, are participating in a cancer vaccine clinical trial. If the study is successful, the work could eventually extend to more cancers or other risk factors, noted Robert H. Vonderheide, MD, DPhil, director of the ACC. Jill Martin's Winning Game Plan: Turning Challenges into Opportunities Hamptons Magazine News | October 2024 TODAY Show contributor and breast cancer survivor Jill Martin launched a new clothing line to raise awareness of breast cancer and genetic testing, with proceeds going to the Basser Center. New Loungewear Collection Raises Money for Breast Cancer Behind the Hedges News | October 2024 “This initiative will support our work dedicated to helping those affected by BRCA gene mutations through treatment, awareness, prevention, and research,” said Susan Domchek, MD, executive director of the Basser Center. The Biology of ‘Precancer’: Stopping Cancer Before It Starts Medscape News | October 2024 A growing effort seeks to understand “precancer”—the critical period after cells have started to grow abnormally but before they’ve developed into cancer. Dr. Susan Domchek is leading a clinical trial for a cancer interception vaccine, which would help the body recognize the earliest signs of cancer and stop the disease before it develops. Basser Center for BRCA Celebrates Breast Cancer Awareness Month TODAY News | October 2024 Susan Domchek, MD, executive director of the Basser Center, took part in a live interview on the TODAY Show with breast cancer survivor and Basser Advisory Board member Jill Martin to share the importance of knowing your family cancer history and how it fits into genetic testing. NBA/WNBA Sherpa Jackets Support Basser Center for BRCA TODAY News | October 2024 TODAY Show contributor and breast cancer survivor Jill Martin launched a new clothing collaboration with the NBA and WNBA to raise awareness of breast cancer and genetic testing, especially for cancers related to the BRCA gene mutation. The Future of Breast Cancer Treatment ABC7NY News | October 2024 Dr. Susan Domchek spoke with breast cancer survivor and Basser Advisory Board member, reporter Stacey Sager, about how the future of breast cancer treatment is brighter than ever, with a wealth of new therapies and research making it into the clinic. BRCA Testing in Male Patients Slipping Through the Net EMJ Reviews News | September 2024 Kara Maxwell, MD, PhD, highlighted that BRCA genetic testing rates among men remain striking low, despite a heightened risk of breast, pancreatic, and prostate cancers in males with BRCA mutations. Oncologists, Primary Care Clinicians Should Be Aware of BRCA Testing Indications in Men Healio News | September 2024 Although men with BRCA mutations are at greater risk for breast, pancreatic, or prostate cancers, Dr. Kara Maxwell states BRCA testing is underutilized in men. Basser Center Board Member and Reporter Discusses Cancer Treatment ABC7NY News | September 2024 Basser executive director Susan Domchek, MD, explains how a class of drugs called PARP inhibitors can help treat cancers related to BRCA mutations to ABC7 news reporter Stacey Sager, a member of the Basser Center Advisory Board who shared an update on her cancer journey. Awareness Efforts Needed to Address Genetic Testing Disparities Among Male BRCA1/2 Carriers OncLive News | August 2024 Kara Maxwell, MD, PhD, director of the Basser Center for BRCA’s Men & BRCA program, explained why clinicians should be “vigilant” about offering genetic testing to men. Cancer Risk for Males Carrying Germline BRCA Mutations OncLive News | August 2024 Kara Maxwell, MD, PhD, director of the Basser Center’s Men & BRCA program, explained that although males are equally as likely to harbor germline BRCA mutations, a lower proportion of males undergo cancer genetic testing compared with females. BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients JAMA Network News | July 2024 Kara Maxwell, MD, PhD, director of our Men & BRCA program, worked with CureBRCA to publish a new paper that compiles various approved guidelines for men with BRCA mutations, including statistical tables that compare the risks of certain cancers for men with BRCA1 and BRCA2 genetic mutations. Big-Time Athletes Swing for a Cure at Mid Penn Bank Celebrity Golf Classic FOX43 News | July 2024 Money raised from the Mid Penn Bank Celebrity Golf Classic at Hershey Country Club will support cancer research at the Pennsylvania Breast Cancer Coalition and the Basser Center for BRCA at Penn Medicine. Determining Individual Risk for Ovarian Cancer in Primary Care Settings Healio News | July 2024 Ronny Drapkin, MD, PhD, discusses risk factors for ovarian cancer, the importance of raising awareness among PCPs and OB-GYNs, and when health care providers should discuss family history and genetic testing with their patients. Diagnostic Challenges and Treatment Advances in Ovarian Cancer Healio News | July 2024 Ronny Drapkin, MD, PhD, director of the Penn Ovarian Cancer Research Center and director of Gynecologic Cancer Research in the Basser Center for BRCA, discussed why it’s difficult to detect ovarian cancer in its earliest stages and how new drugs like PARP inhibitors have made a difference in ovarian cancer treatment. Men with Cancer History Often Do Not Receive Recommended Genetic Testing HemOnc Today News | June 2024 A recent study from Kara Maxwell, MD, PhD showed only a small percentage of men recommended to undergo genetic testing due to personal or family history of cancer actually received it. She hopes the study will motivate health care providers to introduce genetic testing to more patients. Pagination Current page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 … Next page›› Last pageLast »
Basser Center for BRCA Celebrates Breast Cancer Awareness Month TODAY News Susan Domchek, MD, executive director of the Basser Center, took part in a live interview on the TODAY Show with breast cancer survivor and Basser Advisory Board member Jill Martin.
Basser Center for BRCA Awards 2024 Basser Global Prize to Patrick Sung, DPhil, of The University of Texas Health Science Center at San Antonio Penn Medicine News News | October 2024 Patrick Sung, DPhil, of The University of Texas Health Science Center at San Antonio is awarded the 2024 Basser Global Prize for his cutting-edge work in the field of DNA damage repair.
Can We Prevent Cancer With a Shot? The Wall Street Journal News | October 2024 Healthy volunteers who carry BRCA gene mutations, like Philadelphia resident Sara Walker, are participating in a cancer vaccine clinical trial. If the study is successful, the work could eventually extend to more cancers or other risk factors, noted Robert H. Vonderheide, MD, DPhil, director of the ACC.
Jill Martin's Winning Game Plan: Turning Challenges into Opportunities Hamptons Magazine News | October 2024 TODAY Show contributor and breast cancer survivor Jill Martin launched a new clothing line to raise awareness of breast cancer and genetic testing, with proceeds going to the Basser Center.
New Loungewear Collection Raises Money for Breast Cancer Behind the Hedges News | October 2024 “This initiative will support our work dedicated to helping those affected by BRCA gene mutations through treatment, awareness, prevention, and research,” said Susan Domchek, MD, executive director of the Basser Center.
The Biology of ‘Precancer’: Stopping Cancer Before It Starts Medscape News | October 2024 A growing effort seeks to understand “precancer”—the critical period after cells have started to grow abnormally but before they’ve developed into cancer. Dr. Susan Domchek is leading a clinical trial for a cancer interception vaccine, which would help the body recognize the earliest signs of cancer and stop the disease before it develops.
Basser Center for BRCA Celebrates Breast Cancer Awareness Month TODAY News | October 2024 Susan Domchek, MD, executive director of the Basser Center, took part in a live interview on the TODAY Show with breast cancer survivor and Basser Advisory Board member Jill Martin to share the importance of knowing your family cancer history and how it fits into genetic testing.
NBA/WNBA Sherpa Jackets Support Basser Center for BRCA TODAY News | October 2024 TODAY Show contributor and breast cancer survivor Jill Martin launched a new clothing collaboration with the NBA and WNBA to raise awareness of breast cancer and genetic testing, especially for cancers related to the BRCA gene mutation.
The Future of Breast Cancer Treatment ABC7NY News | October 2024 Dr. Susan Domchek spoke with breast cancer survivor and Basser Advisory Board member, reporter Stacey Sager, about how the future of breast cancer treatment is brighter than ever, with a wealth of new therapies and research making it into the clinic.
BRCA Testing in Male Patients Slipping Through the Net EMJ Reviews News | September 2024 Kara Maxwell, MD, PhD, highlighted that BRCA genetic testing rates among men remain striking low, despite a heightened risk of breast, pancreatic, and prostate cancers in males with BRCA mutations.
Oncologists, Primary Care Clinicians Should Be Aware of BRCA Testing Indications in Men Healio News | September 2024 Although men with BRCA mutations are at greater risk for breast, pancreatic, or prostate cancers, Dr. Kara Maxwell states BRCA testing is underutilized in men.
Basser Center Board Member and Reporter Discusses Cancer Treatment ABC7NY News | September 2024 Basser executive director Susan Domchek, MD, explains how a class of drugs called PARP inhibitors can help treat cancers related to BRCA mutations to ABC7 news reporter Stacey Sager, a member of the Basser Center Advisory Board who shared an update on her cancer journey.
Awareness Efforts Needed to Address Genetic Testing Disparities Among Male BRCA1/2 Carriers OncLive News | August 2024 Kara Maxwell, MD, PhD, director of the Basser Center for BRCA’s Men & BRCA program, explained why clinicians should be “vigilant” about offering genetic testing to men.
Cancer Risk for Males Carrying Germline BRCA Mutations OncLive News | August 2024 Kara Maxwell, MD, PhD, director of the Basser Center’s Men & BRCA program, explained that although males are equally as likely to harbor germline BRCA mutations, a lower proportion of males undergo cancer genetic testing compared with females.
BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients JAMA Network News | July 2024 Kara Maxwell, MD, PhD, director of our Men & BRCA program, worked with CureBRCA to publish a new paper that compiles various approved guidelines for men with BRCA mutations, including statistical tables that compare the risks of certain cancers for men with BRCA1 and BRCA2 genetic mutations.
Big-Time Athletes Swing for a Cure at Mid Penn Bank Celebrity Golf Classic FOX43 News | July 2024 Money raised from the Mid Penn Bank Celebrity Golf Classic at Hershey Country Club will support cancer research at the Pennsylvania Breast Cancer Coalition and the Basser Center for BRCA at Penn Medicine.
Determining Individual Risk for Ovarian Cancer in Primary Care Settings Healio News | July 2024 Ronny Drapkin, MD, PhD, discusses risk factors for ovarian cancer, the importance of raising awareness among PCPs and OB-GYNs, and when health care providers should discuss family history and genetic testing with their patients.
Diagnostic Challenges and Treatment Advances in Ovarian Cancer Healio News | July 2024 Ronny Drapkin, MD, PhD, director of the Penn Ovarian Cancer Research Center and director of Gynecologic Cancer Research in the Basser Center for BRCA, discussed why it’s difficult to detect ovarian cancer in its earliest stages and how new drugs like PARP inhibitors have made a difference in ovarian cancer treatment.
Men with Cancer History Often Do Not Receive Recommended Genetic Testing HemOnc Today News | June 2024 A recent study from Kara Maxwell, MD, PhD showed only a small percentage of men recommended to undergo genetic testing due to personal or family history of cancer actually received it. She hopes the study will motivate health care providers to introduce genetic testing to more patients.